Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Psoriasis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriasis Therapeuticsmarket, defines the market attractiveness level of Psoriasis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Psoriasis Therapeutics industry, describes the types of Psoriasis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriasis Therapeutics market and the development prospects and opportunities of Psoriasis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriasis Therapeutics market in Chapter 13.
By Player:
Astellas Pharma Inc
AstraZeneca plc
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Valeant Pharmaceuticals International, Inc
Merck & Co, Inc
Eli Lilly and Company
Biocon Limited
G & W Laboratories Inc
F Hofffmann-La Roche
By Type:
Oral
Parenteral
Topical
By End-User:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Psoriasis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Psoriasis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Psoriasis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Psoriasis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Psoriasis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Psoriasis Therapeutics Consumption (2017-2022)
-
7.2 United States Psoriasis Therapeutics Consumption (2017-2022)
-
7.3 Europe Psoriasis Therapeutics Consumption (2017-2022)
-
7.4 China Psoriasis Therapeutics Consumption (2017-2022)
-
7.5 Japan Psoriasis Therapeutics Consumption (2017-2022)
-
7.6 India Psoriasis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Psoriasis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Psoriasis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Psoriasis Therapeutics Consumption Forecast (2022-2028)
9 Global Psoriasis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Parenteral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2.2 Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Psoriasis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Psoriasis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Psoriasis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Psoriasis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Psoriasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Psoriasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Psoriasis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Psoriasis Therapeutics Market Competitive Analysis
-
14.1 Astellas Pharma Inc
-
14.1.1 Astellas Pharma Inc Company Details
-
14.1.2 Astellas Pharma Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Pharma Inc Psoriasis Therapeutics Product and Service
-
14.2 AstraZeneca plc
-
14.2.1 AstraZeneca plc Company Details
-
14.2.2 AstraZeneca plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca plc Psoriasis Therapeutics Product and Service
-
14.3 Boehringer Ingelheim GmbH
-
14.3.1 Boehringer Ingelheim GmbH Company Details
-
14.3.2 Boehringer Ingelheim GmbH Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Service
-
14.4 GlaxoSmithKline plc
-
14.4.1 GlaxoSmithKline plc Company Details
-
14.4.2 GlaxoSmithKline plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline plc Psoriasis Therapeutics Product and Service
-
14.5 Valeant Pharmaceuticals International, Inc
-
14.5.1 Valeant Pharmaceuticals International, Inc Company Details
-
14.5.2 Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Product and Service
-
14.6 Merck & Co, Inc
-
14.6.1 Merck & Co, Inc Company Details
-
14.6.2 Merck & Co, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck & Co, Inc Psoriasis Therapeutics Product and Service
-
14.7 Eli Lilly and Company
-
14.7.1 Eli Lilly and Company Company Details
-
14.7.2 Eli Lilly and Company Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly and Company Psoriasis Therapeutics Product and Service
-
14.8 Biocon Limited
-
14.8.1 Biocon Limited Company Details
-
14.8.2 Biocon Limited Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biocon Limited Psoriasis Therapeutics Product and Service
-
14.9 G & W Laboratories Inc
-
14.9.1 G & W Laboratories Inc Company Details
-
14.9.2 G & W Laboratories Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 G & W Laboratories Inc Psoriasis Therapeutics Product and Service
-
14.10 F Hofffmann-La Roche
-
14.10.1 F Hofffmann-La Roche Company Details
-
14.10.2 F Hofffmann-La Roche Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 F Hofffmann-La Roche Psoriasis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Psoriasis Therapeutics
-
Figure Psoriasis Therapeutics Picture
-
Table Global Psoriasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Psoriasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Psoriasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Psoriasis Therapeutics Product and Service
-
Table AstraZeneca plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc Psoriasis Therapeutics Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Psoriasis Therapeutics Product and Service
-
Table Valeant Pharmaceuticals International, Inc (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Psoriasis Therapeutics Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Psoriasis Therapeutics Product and Service
-
Table Biocon Limited (Foundation Year, Company Profile and etc.)
-
Table Biocon Limited Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited Psoriasis Therapeutics Product and Service
-
Table G & W Laboratories Inc (Foundation Year, Company Profile and etc.)
-
Table G & W Laboratories Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table G & W Laboratories Inc Psoriasis Therapeutics Product and Service
-
Table F Hofffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hofffmann-La Roche Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hofffmann-La Roche Psoriasis Therapeutics Product and Service
-
